Lumexa Imaging Holdings (LMRI) Q2 FY26 earnings call

Lumexa Imaging delivered a strong second quarter, marked by record advanced modality volumes and robust free cash flow generation, reflecting the benefits of debt paydown and strategic investments. The company reaffirmed its full-year guidance, driven by successful de novo center ramps and a growing pipeline of health system partnerships, particularly with the new HSS joint venture. Management remains confident in its outpatient imaging model, which is further validated by proposed site-neutral payment rules.